Neil Peart Neurosurgery Resident Research Award
Funding Amount
Not stated
Deadline
Deadline not published
Grant Type
Foundation
Deadline history & next window
- Cycle
- Annual
- Tracked since
- April 2026
Source: the cycle recorded on this listing. Confirm dates with the funder.
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Eligible organizations
- University of Pittsburgh Medical Center
- University of California
- Yale New Haven Hospital
- Columbia University
Other requirements
- Research conducted at leading medical centers including:
- MD Anderson Cancer Center
- Harvard Medical Center/MGH
- Weill-Cornell Medical Center
Overview
Focus Area: Neurosurgery resident research on glioblastoma
Geographic Scope: United States (multi-center)
Award Purpose: Identifies and cultivates the neurosurgeons of tomorrow who will be leaders in glioblastoma research. Supports cutting-edge translational research that can be implemented to extend patient survival.
Program History
- Established: 2020, in honor of legendary Rush drummer Neil Peart
- Initial Recipients: 1 resident (2020)
- Expanded: 2021 to support 7 neurosurgery residents conducting research across the country
Named After
Neil Peart, legendary drummer and lyricist from the band Rush. Recognized as one of the greatest musicians and drummers of all time. Inducted into the Rock and Roll Hall of Fame with his bandmates Geddy Lee and Alex Lifeson in 2013.
Research Focus Areas Supported
Recent recipients' research includes:
- Development of molecular tumor organoids to study glioblastoma stem cells responsible for tumor recurrence
- Personalized medicine approaches for tailoring therapy to individual glioblastoma patients
- Immunotherapy for glioblastoma, including development of IL-2 mimics to promote anti-tumor responses
- CRISPR technology to study genes contributing to immunotherapy resistance
- Liquid biopsy development for diagnosis and monitoring treatment effectiveness
- Drug response testing using organoids to determine effectiveness of drugs and combination therapies
Eligible Institutions
Research conducted at leading medical centers including:
- University of Pittsburgh Medical Center
- MD Anderson Cancer Center
- University of California
- Yale New Haven Hospital
- Harvard Medical Center/MGH
- Columbia University
- Weill-Cornell Medical Center
Mission Alignment
Supports the Glioblastoma Foundation's mission to transform the standard of care for glioblastoma by supporting development of new drugs and effective therapies, with focus on targeted therapies for glioblastoma.
Contact & More Information
- Website: glioblastomafoundation.org
- Organization: Glioblastoma Foundation (501(c)(3) non-profit charitable organization)
- Donation/Support: Can make donations in memory of Neil Peart in support of this award or participate in the 2112 Fundraiser (named after Rush's 1976 concept album)
What Glioblastoma Foundation Inc actually gave
Source: IRS Form 990, 2024
- Grants in 2024
- 4
- Total given
- $89K
- Median grant
- $15K
- Range
- $10K–$50K
- By dollars: New York 56%, Illinois 24%, Maryland 20%. Top recipient cities: New York, NY; Baltimore, MD; Evanston, IL.
Example grants
Trustees of Columbia University in the City of New York · New York, NY
Glioblastoma research
$50K
John Hopkins University · Baltimore, MD
Glioblastoma research
$18K
Northwestern University · Evanston, IL
Glioblastoma research
$12K
Congress of Neurological Surgeons · Schaumburg, IL
Glioblastoma research
$10K
Focus Areas & Funding Uses
Fields of Work
- Science research
- Cancer
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Thomas F. Kirby Glioblastoma Foundation Award for Drug Development
Glioblastoma Foundation Inc
Amount
Varies
Deadline
Deadline not published
Discovery of the Genetic Basis of Childhood Cancers and of Congenital Anomalies: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
January 11, 2027
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
October 8, 2027
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Up to $500,000
Deadline
November 22, 2028
Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
National Institutes of Health
Amount
Varies
Deadline
July 5, 2029
Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)
National Institutes of Health
Amount
$25,000,000 total
Deadline
September 25, 2029
Ready to apply for Neil Peart Neurosurgery Resident Research Award?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found Neil Peart Neurosurgery Resident Research Award. Now let's win it.